PROM1 and glioma: All CD133+ glioma cells expressing CD90, and CD90+/CD133+ and CD90+/CD133- cells have the same self-renewal ability, indicating that CD133+ glioma stem cells may be a subtype of CD90+ glioma cells (He et al., 2012).